skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8119

Cardiac risk stratification: Role of the coronary calcium score

Review

(2756) Views  (776) Full article downloads

Authors: Rakesh K Sharma, Rajiv K Sharma, Donald J Voelker, et al

Published Date July 2010 Volume 2010:6 Pages 603 - 611
DOI: http://dx.doi.org/10.2147/VHRM.S8753

Rakesh K Sharma1, Rajiv K Sharma1, Donald J Voelker1, Vibhuti N Singh2, Deepak Pahuja3, Teresa Nash1, Hanumanth K Reddy1

1Medical Center of South Arkansas, University of Arkansas for Medical Sciences, Little Rock, AR, USA; 2Bayfront Medical Center, St Petersburg, Florida; 3Saint Vincent Health Center, Erie, PA, USA

Abstract: Coronary artery calcium (CAC) is an integral part of atherosclerotic coronary heart disease (CHD). CHD is the leading cause of death in industrialized nations and there is a constant effort to develop preventative strategies. The emphasis is on risk stratification and primary risk prevention in asymptomatic patients to decrease cardiovascular mortality and morbidity. The Framingham Risk Score predicts CHD events only moderately well where family history is not included as a risk factor. There has been an exploration for new tests for better risk stratification and risk factor modification. While the Framingham Risk Score, European Systematic Coronary Risk Evaluation Project, and European Prospective Cardiovascular Munster study remain excellent tools for risk factor modification, the CAC score may have additional benefit in risk assessment. There have been several studies supporting the role of CAC score for prediction of myocardial infarction and cardiovascular mortality. It has been shown to have great scope in risk stratification of asymptomatic patients in the emergency room. Additionally, it may help in assessment of progression or regression of coronary artery disease. Furthermore, the CAC score may help differentiate ischemic from nonischemic cardiomyopathy.

Keywords: coronary calcium scoring, coronary artery disease, CAC, cardiomyopathy, angiography, chest pain, Framingham, risk stratification, risk factors





 

Other articles by Dr Rakesh Sharma

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
Coronary computed tomographic angiography (CCTA) in community hospitals: “current and emerging role”
Evolving role of platelet function testing in coronary artery interventions
The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University